Mariko Nakayama

177Lu-Prostate-Specific Membrane Antigen Neoadjuvant to Stereotactic Ablative Radiotherapy for Oligorecurrent Prostate Cancer (LUNAR): An Open-Label, Randomized, Controlled, Phase…

Journal of Clinical Oncology · 2025 · 21 citations

Diagnostic and Therapeutic Application of Fibroblast Activation Protein Inhibitors in Oncologic and Nononcologic Diseases

Review · The Cancer Journal · 2024 · First of 3 authors · 7 citations